Clinical trial
PD0332991/Paclitaxel in Advanced Breast Cancer
NCT01320592
Study timeline
Study start (actual)2011-03-01Date precision: month
Registry last updated2020-04-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
PD0332991DRUG
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Abramson Cancer Center at Penn Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01320592 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.